Mark Rutz

1.9k total citations · 1 hit paper
11 papers, 1.6k citations indexed

About

Mark Rutz is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Mark Rutz has authored 11 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Mark Rutz's work include Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Mark Rutz is often cited by papers focused on Immune Response and Inflammation (8 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Mark Rutz collaborates with scholars based in Germany and United States. Mark Rutz's co-authors include Hermann Wagner, Stefan Bauer, Parviz Ahmad‐Nejad, R. Martin Vabulas, Hans Häcker, Jochen Metzger, Peter B. Luppa, Grayson B. Lipford, Guangxun Meng and Carsten J. Kirschning and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and The FASEB Journal.

In The Last Decade

Mark Rutz

11 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

2002 585 citations Parviz Ahmad‐Nejad, Hans Häcker et al. European Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Rutz Germany	9	1.2k	418	242	209	139	11	1.6k
Sally T. Ishizaka United States	15	1.1k 0.9×	386 0.9×	311 1.3×	125 0.6×	136 1.0×	28	1.7k
Ryutaro Fukui Japan	21	1.3k 1.1×	548 1.3×	270 1.1×	117 0.6×	110 0.8×	39	1.8k
Cathrine Knetter United States	7	1.1k 0.9×	347 0.8×	233 1.0×	162 0.8×	105 0.8×	7	1.3k
Philippe Dje N’Guessan Germany	23	707 0.6×	696 1.7×	306 1.3×	191 0.9×	100 0.7×	35	1.6k
Ana Fontalba Spain	17	1.2k 1.0×	760 1.8×	399 1.6×	198 0.9×	151 1.1×	25	2.3k
John S. Cowdery United States	17	1.3k 1.0×	358 0.9×	177 0.7×	116 0.6×	76 0.5×	44	1.6k
Anne M. Stevens United States	18	1.3k 1.1×	397 0.9×	352 1.5×	217 1.0×	189 1.4×	26	2.1k
Roman Barbalat United States	8	1.5k 1.2×	684 1.6×	319 1.3×	98 0.5×	151 1.1×	8	2.0k
Şefik Ş. Alkan United States	23	1.7k 1.4×	518 1.2×	555 2.3×	148 0.7×	129 0.9×	44	2.8k
Bettina L. Lee United States	11	1.3k 1.1×	1.0k 2.5×	224 0.9×	104 0.5×	220 1.6×	13	2.1k

Countries citing papers authored by Mark Rutz

Since Specialization

Citations

This map shows the geographic impact of Mark Rutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rutz more than expected).

Fields of papers citing papers by Mark Rutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rutz. The network helps show where Mark Rutz may publish in the future.

Co-authorship network of co-authors of Mark Rutz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Rutz. A scholar is included among the top collaborators of Mark Rutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Rutz. Mark Rutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Peralta, E., et al.. (2010). GPR30 Is an Estrogen Receptor in Breast Cancer that Increases Tamoxifen Resistance. Journal of Surgical Research. 158(2). 335–336. 1 indexed citations

2.

Yasuda, Kei, Mark Rutz, Jochen Metzger, et al.. (2006). CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA. European Journal of Immunology. 36(2). 431–436. 96 indexed citations

3.

Meng, Guangxun, Alina Grabiec, Mark Rutz, et al.. (2004). Murine TLR2 expression analysis and systemic antagonism by usage of specific monoclonal antibodies. Immunology Letters. 98(2). 200–207. 8 indexed citations

4.

Fischer, Silke, Susanne Kirschnek, Mark Rutz, et al.. (2004). Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis. Immunology Letters. 97(1). 115–122. 25 indexed citations

5.

Meng, Guangxun, Mark Rutz, Matthias Schiemann, et al.. (2004). Antagonistic antibody prevents toll-like receptor 2–driven lethal shock-like syndromes. Journal of Clinical Investigation. 113(10). 1473–1481. 172 indexed citations

6.

Rutz, Mark, Jochen Metzger, Peter B. Luppa, et al.. (2004). Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner. European Journal of Immunology. 34(9). 2541–2550. 421 indexed citations

7.

Anders, Hans‐Joachim, Volker Vielhauer, Václav Eis, et al.. (2004). Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) mice. The FASEB Journal. 18(3). 534–536. 173 indexed citations

8.

Meng, Guangxun, Mark Rutz, Matthias Schiemann, et al.. (2004). Antagonistic antibody prevents toll-like receptor 2–driven lethal shock-like syndromes. Journal of Clinical Investigation. 113(10). 1473–1481. 18 indexed citations

9.

Meng, Guangxun, Mark Rutz, Alina Grabiec, et al.. (2004). PREVENTION OF EXPERIMENTAL TLR2 DRIVEN SHOCK BY APPLICATION OF SPECIFIC INHIBITOR PROTEINS. Shock. 21(Supplement). 65–65. 1 indexed citations

10.

Feil, Robert, Mark Rutz, Jens Schlossmann, et al.. (2002). Functional Reconstitution of Vascular Smooth Muscle Cells With cGMP-Dependent Protein Kinase I Isoforms. Circulation Research. 90(10). 1080–1086. 91 indexed citations

11.

Ahmad‐Nejad, Parviz, Hans Häcker, Mark Rutz, et al.. (2002). Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. European Journal of Immunology. 32(7). 1958–1958. 585 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact